Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001748462-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-12 | 2026-02-10 | COLL | Smith Thomas B | EVP, Chief Medical Off | F - Tax | $46.75 | -17.4K | 90.7K | -16% | -$815.1K |
| M | 2026-02-12 | 2026-02-10 | COLL | Smith Thomas B | EVP, Chief Medical Off | A - Grant | $0.00 | +37.0K | 85.3K | +77% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | F | D | 5,897 | $46.75 | 102,189 | D | — | — | (F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. |
| 2 | Common | Common Stock | 2026-02-10 | F | D | 11,538 | $46.75 | 90,651 | D | — | — | (F5) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. |
| 3 | Common | Common Stock | 2026-02-10 | A | A | 22,774 | $0.00 | 108,086 | D | — | — | (F3) Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,774 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. |
| 4 | Common | Common Stock | 2026-02-10 | A | A | 14,268 | $0.00 | 85,312 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. (F2) Includes 376 and 404 shares acquired on July 18, 2025 and January 16, 2026, respectively, under the Issuer's employee stock purchase plan. |